Danazol: An Effective Option in Acquired Amegakaryocytic Thrombocytopaenic Purpura
Joint Authors
Mulroy, E.
Gleeson, S.
Chiruka, S.
Source
Issue
Vol. 2015, Issue 2015 (31 Dec. 2015), pp.1-4, 4 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2015-04-05
Country of Publication
Egypt
No. of Pages
4
Main Subjects
Abstract EN
Acquired amegakaryocytic thrombocytopaenic purpura (AATP) is a rare haematological condition characterised by isolated thrombocytopaenia with normal other cell lines.
It is often initially misdiagnosed as immune thrombocytopaenic purpura but has characteristic bone marrow findings of reduced megakaryocyte numbers.
The optimal treatment of AATP is not clearly defined but revolves around immunosuppressive therapies.
We report a case of successful treatment of AATP with danazol, an antioestrogenic medication.
We also review the aetiologies and pathogenesis of the disorder and suggest that danazol should be considered as an effective alternative to potent immunosuppression in AATP.
American Psychological Association (APA)
Mulroy, E.& Gleeson, S.& Chiruka, S.. 2015. Danazol: An Effective Option in Acquired Amegakaryocytic Thrombocytopaenic Purpura. Case Reports in Hematology،Vol. 2015, no. 2015, pp.1-4.
https://search.emarefa.net/detail/BIM-1058582
Modern Language Association (MLA)
Mulroy, E.…[et al.]. Danazol: An Effective Option in Acquired Amegakaryocytic Thrombocytopaenic Purpura. Case Reports in Hematology No. 2015 (2015), pp.1-4.
https://search.emarefa.net/detail/BIM-1058582
American Medical Association (AMA)
Mulroy, E.& Gleeson, S.& Chiruka, S.. Danazol: An Effective Option in Acquired Amegakaryocytic Thrombocytopaenic Purpura. Case Reports in Hematology. 2015. Vol. 2015, no. 2015, pp.1-4.
https://search.emarefa.net/detail/BIM-1058582
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1058582